Anda di halaman 1dari 1

STATUS ASTHMATICUS Late inflammatory response

Introduction Release of inflammatory mediators prime adhesion


-Status asthmaticus is an acute exacerbation of asthma molecules in the airway epithelium and capillary
that remains unresponsive to initial treatment with endothelium, which then allows inflammatory cells, such
bronchodilators. as eosinophils, neutrophils, and basophils, to attach to the
-Patients report chest tightness, rapidly progressive epithelium and endothelium and subsequently migrate
shortness of breath, dry cough, and wheezing. into the tissues of the airway.
-Typically, patients present a few days after the onset of a Eosinophils release eosinophilic cationic protein (ECP)
viral respiratory illness, following exposure to a potent and major basic protein (MBP). Both ECP and MBP
allergen or irritant, or after exercise in a cold induce desquamation of the airway epithelium and
environment. expose nerve endings. This interaction promotes further
Pathophysiology airway hyperresponsiveness in asthma.
-Allergic inflammation in asthma begins with the The 2 phases of asthma lead to:
development of a predominantly helper T2 lymphocyte–  increased airway resistance and obstruction.
driven, as opposed to helper T1 lymphocyte–driven,
immune milieu, perhaps caused by certain types of  Air trapping results in lung hyperinflation
immune stimulation early in life.  Ventilation/perfusion (V/Q) mismatch
-This is followed by allergen exposure in a genetically
susceptible individual. Specific allergen exposure (eg,  Increased dead space ventilation.
dust mites) under the influence of helper T2 lymphocytes  Decreased compliance and increased work of
leads to B-lymphocyte elaboration of immunoglobulin E breathing.
(IgE) antibodies specific to that allergen. -The increased pleural and intra-alveolar pressures that
-The IgE antibody attaches to surface receptors on airway result from obstruction and hyperinflation, together with
mucosal mast cells. the mechanical forces of the distended alveoli, eventually
-Subsequent specific allergen exposure leads to cross- lead to a decrease in alveolar perfusion.
bridging of IgE molecules and activation of mast cells, -The combination of atelectasis and decreased perfusion
with elaboration and release of a vast array of mediators. leads to V/Q mismatch within lung units. The V/Q
-These mediators include histamine; leukotrienes C4, D4, mismatch and resultant hypoxemia trigger an increase in
and E4; and a host of cytokines. minute ventilation.
-These mediators cause: The early stages of acute asthma, hyperventilation may
 Bronchial smooth muscle constriction result in respiratory alkalosis but later respiratory acidosis
 Vascular leakage occurs V/Q mismatch.
 Inflammatory cell recruitment (with further Sex: In infants, males generally have more severe disease
than females.
mediator release)
In older children, males and females are equally affected.
 Mucous gland secretion
Asthma has a higher incidence among adult females.
-These processes lead to airway obstruction by
Age:
constriction of the smooth muscles, edema of the
Asthma is well distributed among people of all age
airways, influx of inflammatory cells, and formation of
groups.
intraluminal mucus.
Children who have asthma in the first year of life and
-In addition, ongoing airway inflammation is thought to
those aged 9-16 years tend to have much more severe
cause the airway hyperreactivity characteristic of asthma.
disease.
-Physiologically, asthma has 2 components: an early
DDx
acute bronchospastic aspect marked by smooth muscle
-Pulmonary Hypertension, Primary
bronchoconstriction and a later inflammatory component
-Congestive heart failure- Orthopnea, moist basilar rales,
resulting in airway swelling and edema.
gallop rhythms, blood-tinged sputum
Early bronchospastic response
-Croup
Mediators, including histamine, prostaglandin D2, and
-Stridor
leukotriene C4. These substances cause airway smooth
-Upper airway obstruction
muscle contraction, increased capillary permeability,
-Foreign-body aspiration
mucus secretion, and activation of neuronal reflexes.
-Neoplasm
Early asthmatic response is characterized by
-Bronchial stenosis.
bronchoconstriction that is generally responsive to
-Recurrent episodes of bronchospasm can occur with
bronchodilators, such as beta2-agonist agents
carcinoid tumors
-Recurrent pulmonary emboli
- Chronic bronchitis
- Eosinophilic pneumonias are often associated with
asthmatic symptoms, as are various chemical pneumonias
and exposures to insecticides and cholinergic drugs.
-Bronchospasm occasionally is a manifestation of
systemic vasculitis with pulmonary involvement.

Clinical presentation
History INVESTIGATIONS
-The symptoms of asthma consist of a triad of 1-Spirometry
 Dyspnea -The diagnosis of asthma is established by demonstrating
 Cough reversible airway obstruction.
-The evaluation for asthma should include spirometry
 wheezing (FEV1, FVC, FEV1/FVC) before and after the
 Chest tightness
-Wheezing regarded as the sine qua non for asthma. administration of a short-acting bronchodilator.
-Cough is non productive initially then thick sputum -Reversibility is traditionally defined as a 15% or
later greater increase in FEV1 after two puffs of a b-
- Personal or family history of allergic diseases such as adrenergic agonist
eczema, rhinitis, or urticaria is valuable contributory -In severe airflow obstruction with significant air
evidence.

Anda mungkin juga menyukai